First Citizens Bank & Trust Co. Has $3.11 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

First Citizens Bank & Trust Co. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.5% during the 4th quarter, HoldingsChannel reports. The fund owned 10,362 shares of the company’s stock after selling 157 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in HCA Healthcare were worth $3,110,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare during the second quarter worth about $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter worth about $39,000. Canoe Financial LP bought a new position in HCA Healthcare in the 3rd quarter valued at approximately $41,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the 3rd quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC bought a new position in HCA Healthcare during the 3rd quarter worth approximately $44,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have issued reports on HCA. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Oppenheimer lifted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Stock Down 4.0 %

HCA stock opened at $312.51 on Monday. HCA Healthcare, Inc. has a twelve month low of $279.93 and a twelve month high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market capitalization of $79.16 billion, a PE ratio of 14.03, a PEG ratio of 1.09 and a beta of 1.64. The stock has a 50-day simple moving average of $313.49 and a two-hundred day simple moving average of $352.87.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter last year, the business earned $5.90 earnings per share. On average, equities analysts predict that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.